Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
  4. Volume 25, Issue 7
  5. Article
Volume 25, Issue 7
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Lung cancer is correlated with a high death rate, with approximately 1.8 million mortality cases reported worldwide in 2022. Despite development in the control of lung cancer, most cases are detected at higher stages with short survival rates. This reveals a need to recognize novel techniques to treat malignancy and decrease the burden of lung cancer. Long noncoding RNAs (lncRNAs) manage vital cellular and biochemical functions. lncRNAs play crucial roles in transcriptional and translational processes and signaling cascades. Recently, lncRNAs have been reported to be associated with malignancy where their expression is deregulated, leading to abnormal cellular activities and signaling pathways. In various malignancies, including lung cancer, lncRNA deregulation disrupts normal cellular function, promoting tumorigenesis and influencing patient outcomes and treatment responses. Studies have shown that lncRNAs can act as both oncogenes and tumor suppressors, depending on the lung cancer subtype, specifically in Non-small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). This dual role of lncRNAs as critical biomarkers might provide insights into lung cancer development and progression. lncRNAs have been discussed as key biomarkers in lung cancer. A comprehensive understanding of the biological activities of lncRNAs in NSCLC and SCLC may improve prognosis, diagnosis, and therapeutic methods. Researchers are increasingly interested in lncRNAs as potential diagnostic biomarkers and therapeutic targets in cancer treatment. As researchers continue to explore lncRNAs, their pivotal roles in lung cancer become increasingly evident. This review highlights the function of lncRNAs in lung carcinogenesis and discusses their molecular mechanisms of function.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206336608241104065557
2025-01-01
2025-04-06

  • From This Site

    /content/journals/acamc/10.2174/0118715206336608241104065557
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZappaC. MousaS.A. Non-small cell lung cancer: Current treatment and future advances.Transl. Lung Cancer Res.20165328830010.21037/tlcr.2016.06.07
     [Google Scholar]
  2. DenisenkoT.V. BudkevichI.N. ZhivotovskyB. Cell death-based treatment of lung adenocarcinoma.Cell Death Dis.20189211710.1038/s41419‑017‑0063‑y
     [Google Scholar]
  3. SouzaV.G.P. de AraújoR.P. SantessoM.R. SenedaA.L. MinutentagI.W. FelixT.F. H FilhoP.T. PewarchukM.E. BrockleyL.J. MarchiF.A. LamW.L. DrigoS.A. ReisP.P. Advances in the molecular landscape of lung cancer brain metastasis.Cancers (Basel)202315372210.3390/cancers15030722
     [Google Scholar]
  4. MezentsevA. DurymanovM. MakarovV.A. A comprehensive review of protein biomarkers for invasive lung cancer.Curr. Oncol.20243194818485410.3390/curroncol31090360
     [Google Scholar]
  5. ArunkumarG. LncRNAs: The good, the bad, and the unknown.Biochem. Cell Biol.2024102192710.1139/bcb‑2023‑0155
     [Google Scholar]
  6. HuQ. MaH. ChenH. ZhangZ. XueQ. LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside.Cell Death Discov.20228135910.1038/s41420‑022‑01157‑4
     [Google Scholar]
  7. DastmalchiN. SafaralizadehR. Latifi-NavidS. Banan KhojastehS.M. M HussenB. TeimourianS. An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer.Expert Rev. Mol. Diagn.202121101025103610.1080/14737159.2021.1962707
     [Google Scholar]
  8. DastmalchiN. SafaralizadehR. BananK.S.M. The correlation between microRNAs and Helicobacter pylori in gastric cancer.Pathog. Dis.2019774ftz03910.1093/femspd/ftz039
     [Google Scholar]
  9. DastmalchiN. SafaralizadehR. NargesiM.M. LncRNAs: Potential novel prognostic and diagnostic biomarkers in colorectal cancer.Curr. Med. Chem.202027305067507710.2174/0929867326666190227230024
     [Google Scholar]
  10. MohammadrezakhaniH. BaradaranB. ShanehbandiD. AsadiM. HashemzadehS. HajiasgharzadehK. SafaralizadehR. Overexpression and clinicopathological correlation of long noncoding RNA TMPO-AS1 in colorectal cancer patients.J. Gastrointest. Cancer202051395295610.1007/s12029‑019‑00333‑7
     [Google Scholar]
  11. GhodratiR. SafaralizadehR. DastmalchiN. HosseinpourfeiziM. AsadiM. ShirmohammadiM. BaradaranB. Overexpression of lncRNA DLEU1 in gastric cancer tissues compared to adjacent non-tumor tissues.J. Gastrointest. Cancer202253499099410.1007/s12029‑021‑00733‑8
     [Google Scholar]
  12. Gencel-AugustoJ. WuW. BivonaT.G. long non-coding RNAs as emerging targets in lung cancer.Cancers (Basel)20231512313510.3390/cancers15123135
     [Google Scholar]
  13. LuT. WangY. ChenD. LiuJ. JiaoW. Potential clinical application of lncRNAs in non-small cell lung cancer.OncoTargets Ther.2018118045805210.2147/OTT.S178431
     [Google Scholar]
  14. ChenX. ZhouF. RenW. GuoJ. HuangX. PuJ. NiuX. JiangX. LncRNA-AC02278.4 Is a novel prognostic biomarker that promotes tumor growth and metastasis in lung Adenocarcinoma.Front. Oncol.20221286096110.3389/fonc.2022.860961
     [Google Scholar]
  15. ChenC. LiuW.R. ZhangB. ZhangL.M. LiC.G. LiuC. ZhangH. HuoY-S. MaY-C. TianP-F. QiQ. LiJ-J. TangZ. ZhangZ-F. GiacconeG. YueD-S. WangC-L. LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers.Cancer Lett.2020486587010.1016/j.canlet.2020.05.009
     [Google Scholar]
  16. WangM. FuY. ZhongC. GaccheR.N. WuP. Long non-coding RNA and evolving drug resistance in lung cancer.Heliyon2023912e2259110.1016/j.heliyon.2023.e22591
     [Google Scholar]
  17. LiuD. LuX. HuangW. ZhuangW. Long non-coding RNAs in non-small cell lung cancer: Implications for EGFR-TKI resistance.Front. Genet.202314122205910.3389/fgene.2023.1222059
     [Google Scholar]
  18. GuoX. XiaJ. DengK. Long non-coding RNAs: Emerging players in gastric cancer.Tumour Biol.20143511105911060010.1007/s13277‑014‑2548‑y
     [Google Scholar]
  19. DaC. GongC.Y. NanW. ZhouK.S. WuZ-L. ZhangH-H. The role of long non-coding RNA MIAT in cancers.Biomed. Pharmacother.202012911035910.1016/j.biopha.2020.110359
     [Google Scholar]
  20. LeiT. LvZ.Y. FuJ.F. WangZ. FanZ. WangY. LncRNA NBAT-1 is down-regulated in lung cancer and influences cell proliferation, apoptosis and cell cycle.Eur. Rev. Med. Pharmacol. Sci.201822719581962
     [Google Scholar]
  21. ChenT. GaoF. YangT. LiH. LiY. RenH. ChenM. LncRNA HOTAIRM1 inhibits the proliferation and invasion of lung adenocarcinoma cells via the miR-498/WWOX axis.Cancer Manag. Res.2020124379439010.2147/CMAR.S244573
     [Google Scholar]
  22. KadianL.K. VermaD. LohaniN. YadavR. RangaS. GulshanG. PalS. KumariK. ChauhanS.S. Long non-coding RNAs in cancer: Multifaceted roles and potential targets for immunotherapy.Mol. Cell. Biochem.20249123229325410.1007/s11010‑024‑04933‑1
     [Google Scholar]
  23. WangR. XuY. TongL. ZhangX. ZhangS. Recent progress of exosomal lncRNA/circRNA–miRNA–mRNA axis in lung cancer: Implication for clinical application.Front. Mol. Biosci.202411141730610.3389/fmolb.2024.1417306
     [Google Scholar]
  24. ParkS.M. ChoiE.Y. BaeD.H. SohnH.A. KimS.Y. KimY.J. The LncRNA EPEL promotes lung cancer cell proliferation through E2F target activation.Cell. Physiol. Biochem.20184531270128310.1159/000487460
     [Google Scholar]
  25. MaJ. CaoK. LingX. ZhangP. ZhuJ. LncRNA HAR1A suppresses the development of non-small cell lung cancer by inactivating the STAT3 pathway.Cancers (Basel)20221412284510.3390/cancers14122845
     [Google Scholar]
  26. WuC. YangJ. LiR. LinX. WuJ. WuJ. LncRNA WT1-AS/miR-494-3p regulates cell proliferation, apoptosis, migration and invasion via PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer.OncoTargets Ther.20211489190410.2147/OTT.S278233
     [Google Scholar]
  27. LiuM. LiuC. LiX. LiS. RP11-79H23.3 Inhibits the proliferation and metastasis of non-small-cell lung cancer through promoting miR-29c.Biochem. Genet.202361250652010.1007/s10528‑022‑10263‑y
     [Google Scholar]
  28. LaiX.N. LiJ. TangL.B. ChenW.T. ZhangL. XiongL.X. MiRNAs and LncRNAs: Dual roles in TGF-β signaling-regulated metastasis in lung cancer.Int. J. Mol. Sci.2020214119310.3390/ijms21041193
     [Google Scholar]
  29. LiX. WuY. JinY. Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets.Noncoding RNA Res.2024941069107910.1016/j.ncrna.2024.06.010
     [Google Scholar]
  30. ChengZ. LuC. WangH. WangN. CuiS. YuC. WangC. ZuoQ. WangS. LvY. YaoM. JiangL. QinW. Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression.Cancer Lett.202253111310.1016/j.canlet.2022.01.031
     [Google Scholar]
  31. GaoJ. PanT. WangH. WangS. ChaiJ. JinC. LncRNA FAM138B inhibits the progression of non-small cell lung cancer through miR-105-5p.Cell Cycle202322780881710.1080/15384101.2022.2154556
     [Google Scholar]
  32. MiliotisC. SlackF.J. miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.Cancer Lett.202151811512610.1016/j.canlet.2021.05.037
     [Google Scholar]
  33. SunX. QiuX. LncRNA TPTEP1 inhibited the proliferation and metastasis of non-small cell lung cancer cells by targeting miR-761/LATS2 axis.Am. J. Transl. Res.202113886538669
     [Google Scholar]
  34. PanH. PengJ. QiaoX. GaoH. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis.Open Med. (Wars.)20231812023066610.1515/med‑2023‑0666
     [Google Scholar]
  35. TaghvimiS. AbbaszadehS. BananF.B. FardE.S. JamaliZ. NajafabadiM.A. SavardashtakiA. MovahedpourA. LncRNAs roles in chemoresistance of cancer cells.Curr. Mol. Med.202222869170210.2174/1566524021666211027090515
     [Google Scholar]
  36. GuoS. ZhangL. ZhangY. WuZ. HeD. LiX. WangZ. Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition.Aging (Albany NY)201911187553756910.18632/aging.102271
     [Google Scholar]
  37. XiaH. QuX-L. LiuL-Y. QianD-H. JingH-Y. LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy.Eur. Rev. Med. Pharmacol. Sci.2018224
     [Google Scholar]
  38. YangT. LiH. ChenT. RenH. ShiP. ChenM. LncRNA MALAT1 depressed chemo-sensitivity of NSCLC cells through directly functioning on miR-197-3p/p120 catenin axis.Mol. Cells2019423270283
     [Google Scholar]
  39. PanH. YuT. SunL. ChaiW. LiuX. YanM. LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.Transl. Cancer Res.2020963946395910.21037/tcr‑20‑2147
     [Google Scholar]
  40. WangC. TaoX. WeiJ. Effects of LncRNA MEG3 on immunity and autophagy of non-small cell lung carcinoma through IDO signaling pathway.World J. Surg. Oncol.202119124410.1186/s12957‑021‑02346‑8
     [Google Scholar]
  41. ZhuY. ShenY. ChenR. LiH. WuY. ZhangF. HuangW. GuoL. ChenQ. LiuH. KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis.Ann. Transl. Med.202191089189110.21037/atm‑21‑1761
     [Google Scholar]
  42. YuanX. ShenQ. MaW. Long noncoding RNA hotair promotes the progression and immune escape in laryngeal squamous cell carcinoma through MicroRNA-30a/GRP78/PD-L1 axis.J. Immunol. Res.20222022113
     [Google Scholar]
  43. ChenW. HangY. XuW. WuJ. ChenL. ChenJ. MaoY. SongJ. SongJ. WangH. BLACAT1 predicts poor prognosis and serves as oncogenic lncRNA in small‐cell lung cancer.J. Cell. Biochem.201912022540254610.1002/jcb.27548
     [Google Scholar]
  44. HuangY. XiaL. TanX. ZhangJ. ZengW. TanB. YuX. FangW. YangZ. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.Cell. Mol. Biol. Lett.20222714310.1186/s11658‑022‑00343‑7
     [Google Scholar]
  45. XiaY. WangW.C. ShenW.H. XuK. HuY.Y. HanG.H. LiuY-B. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454–3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.Chem. Biol. Interact.202134910965210.1016/j.cbi.2021.109652
     [Google Scholar]
  46. ShenQ. ZhouH. ZhangM. WuR. WangL. WangY. ChenJ. Super enhancer‐LncRNA SENCR promoted cisplatin resistance and growth of NSCLC through upregulating FLI1.J. Clin. Lab. Anal.2022366e2446010.1002/jcla.24460
     [Google Scholar]
  47. YanZ. YangQ. XueM. WangS. HongW. GaoX. YY1-induced lncRNA ZFPM2-AS1 facilitates cell proliferation and invasion in small cell lung cancer via upregulating of TRAF4.Cancer Cell Int.202020110810.1186/s12935‑020‑1157‑7
     [Google Scholar]
  48. DaoR. WuduM. HuiL. JiangJ. XuY. RenH. QiuX. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.Pathol. Res. Pract.2020216315282310.1016/j.prp.2020.152823
     [Google Scholar]
  49. ZhangY. LiY. HanL. ZhangP. SunS. SBF2‐AS1: An oncogenic lncRNA in small‐cell lung cancer.J. Cell. Biochem.20191209154221542810.1002/jcb.28809
     [Google Scholar]
  50. LuoH. ZhangY. QinG. JiangB. MiaoL. LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.BMC Cancer202121182010.1186/s12885‑021‑08365‑8
     [Google Scholar]
  51. WangD. WuW. HuangW. WangJ. LuoL. TangD. LncRNA LUADT1 sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer.BMC Pulm. Med.201919124610.1186/s12890‑019‑0991‑7
     [Google Scholar]
  52. PanJ. FangS. TianH. ZhouC. ZhaoX. TianH. HeJ. ShenW. MengX. JinX. GongZ. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.Mol. Cancer2020191910.1186/s12943‑020‑1133‑9
     [Google Scholar]
  53. SuH. FanG. HuangJ. QiuX. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.Cell Death Dis.202213430710.1038/s41419‑022‑04723‑x
     [Google Scholar]
  54. LiB. ZhuL. LiL. MaR. lncRNA OXCT1-AS1 promotes metastasis in non-small-cell lung cancer by stabilizing LEF1, in vitro and in vivo.Biomed Res. Int.20212021115
     [Google Scholar]
  55. LuG. ZhangY. Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p.PLoS One.2020152e022911810.1371/journal.pone.0229118
     [Google Scholar]
  56. GüçlüE. Eroğlu GüneşC. KurarE. VuralH. Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy.Med. Oncol.202138911310.1007/s12032‑021‑01562‑2
     [Google Scholar]
  57. ZengF. WangQ. WangS. LiangS. HuangW. GuoY. PengJ. LiM. ZhuW. GuoL. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression.Oncogene202039229330710.1038/s41388‑019‑0984‑2
     [Google Scholar]
  58. HuaJ. WangX. MaL. LiJ. CaoG. ZhangS. LinW. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.Mol. Cancer202221112310.1186/s12943‑022‑01595‑9
     [Google Scholar]
  59. ChungE.K. YongS.H. LeeE.H. KimE.Y. ChangY.S. LeeS.H. New targeted therapy for non-small cell lung cancer.Tuberc. Respir. Dis. (Seoul)202386111310.4046/trd.2022.0066
     [Google Scholar]
  60. ShahR. LesterJ.F. Tyrosine kinase inhibitors for the treatment of EGFR mutation-positive non–small-cell lung cancer: A clash of the generations.Clin. Lung Cancer2020213e216e22810.1016/j.cllc.2019.12.003
     [Google Scholar]
  61. LiY. ShenY. XieM. WangB. WangT. ZengJ. HuaH. YuJ. YangM. LncRNAs LCETRL3 and LCETRL4 at chromosome 4q12 diminish EGFR-TKIs efficiency in NSCLC through stabilizing TDP43 and EIF2S1.Signal Transduct. Target. Ther.2022713010.1038/s41392‑021‑00847‑2
     [Google Scholar]
  62. XuL.M. YuanY.J. YuH. WangS. WangP. LINC00665 knockdown confers sensitivity in irradiated non-small cell lung cancer cells through the miR-582-5p/UCHL3/AhR axis.J. Transl. Med.202220135010.1186/s12967‑022‑03516‑2
     [Google Scholar]
  63. ChenZ. ChenZ. XuS. ZhangQ. LncRNA SOX2-OT/miR-30d-5p/PDK1 regulates PD-L1 checkpoint through the mtor signaling pathway to promote non-small cell lung cancer progression and immune escape.Front. Genet.20211267485610.3389/fgene.2021.674856
     [Google Scholar]
  64. XiaR. GengG. YuX. XuZ. GuoJ. LiuH. LiN. LiZ. LiY. DaiX. LuoQ. JiangJ. MiY. LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs.J. Immunother. Cancer202198e00274610.1136/jitc‑2021‑002746
     [Google Scholar]
  65. DuZ. NiuS. WangJ. WuJ. LiS. YiX. SChLAP1 contributes to non-small cell lung cancer cell progression and immune evasion through regulating the AUF1/PD-L1 axis.Autoimmunity202154422523310.1080/08916934.2021.1913582
     [Google Scholar]
  66. LiJ. CheL. XuC. LuD. XuY. LiuM. ChaiW. XIST/miR-34a-5p/PDL1 axis regulated the development of lung cancer cells and the immune function of CD8+ T cells.J. Recept. Signal Transduct. Res.202242546947810.1080/10799893.2021.2019274
     [Google Scholar]
/content/journals/acamc/10.2174/0118715206336608241104065557
Loading
An Updated Review on Dysregulated lncRNAs and their Contribution to the Various Molecular Types of Lung Carcinoma
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) 25, 490 (2025); https://doi.org/10.2174/0118715206336608241104065557
/content/journals/acamc/10.2174/0118715206336608241104065557
/content/journals/acamc/10.2174/0118715206336608241104065557
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): aberrant functions; lncRNAs; Lung cancer; malignancy; molecular mechanism; therapeutic targets

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test